The Role of Checkpoint Inhibitors in Advanced Lung Cancer
Dr. Heather Wakelee discusses the management of lung cancer patients who have early or delayed progression while being treated with an immune checkpoint inhibitor.
First Human Study Taking Place With Fatty Acid Synthase Inhibitor
We spoke with Dr. Gerald Falchook about the first human study of a first-in-class molecule, fatty acid synthase inhibitor known as TVB-2640 for advanced solid tumors.
Lung Cancer Survival Rates Improving With Nivolumab
We spoke with Dr. Julie Brahmer about how survival rates are starting to improve with the use of nivolumab in non-small cell lung cancer.
New Biomarker May Help Detect Metastatic Endometrial Cancer
We spoke with Dr. G. Larry Maxwell, Chair of the Department of Obstetrics and Gynecology at Inova Fairfax Hospital, about a potential new biomarker to help distinguish metastatic versus nonmetastatic disease in endometrial cancer.
The Role of Rucaparib in Ovarian Cancer
We spoke with Dr. Elizabeth Swisher about the ARIEL2 trial and the role of rucaparib in ovarian cancer.
Molecular Characterizations of Diffuse Large B-Cell Lymphoma
We spoke with Dr. Anas Younes about the molecular characteristics of diffuse large B-cell lymphoma.
Analyzing Various Molecular Subtypes in Bladder Cancer
Dr. Roland Seiler presented an analysis of how different bladder cancer molecular subtypes respond to neoadjuvant chemotherapy at the 2017 ASCO Genitourinary Cancer Symposium.
By clicking Accept, you agree to become a member of the UBM Medica Community.